[Clinical evaluation of the compound G 27202-R 2273 oxyphenbutazone (ointment) 5 percent].
D000293:Adolescent; D000328:Adult; D000368:Aged; D002370:Casts, Surgical; D005260:Female; D050723:Fractures, Bone / Q000188:drug therapy; D006406:Hematoma / Q000188:drug therapy; D006801:Humans; D004204:Joint Dislocations / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009824:Ointments; D009985:Orthopedics; D010113:Oxyphenbutazone / Q000008:administration & dosage / Q000627:therapeutic use*; D010146:Pain / Q000188:drug therapy*; D010689:Phlebitis / Q000188:drug therapy; D052256:Tendinopathy / Q000188:drug therapy
D009824:Ointments; D010113:Oxyphenbutazone
Sperimentazione clinica del preparato G 27202-R 2273 ossifenbutazone crema 5 percent.